A new red flag for non‐relapse mortality: Prolonged transfusion dependence in acute myeloid leukemia allogeneic hematopoietic cell transplant recipients

BACKGROUND AND OBJECTIVES: The hematopoietic cell transplantation comorbidity index (HCT-CI) is widely used to evaluate non-relapse mortality (NRM) risks after HCT. We aimed to evaluate whether the lack of transfusion independence (TI) by Day 30 predicted increased NRM independently of HCT-CI in acute myeloid leukemia (AML) allogeneic (allo-) HCT recipients. MATERIALS AND METHODS: The relationships between HCT-CI, TI, and NRM were evaluated using multivariate analyses in this single-center retrospective study. RESULTS: A total of 676 AML allo-HCT recipients were evaluated, including 234 (35%) with HCT-CI score ≥3. Median follow-up among survivors (n = 307) was 7.1 years (range: 2.7-11.8). High (≥3) HCT-CI score was significantly associated with increased NRM at 2 years but showed no correlation with attainment of red blood cell (RBC) or platelet (PLT) TI by Day 30. However, the lack of RBC or PLT TI by Day 30 predicted higher NRM independently of HCT-CI. The 2-year NRM incidences were 0.297 (95% confidence interval [CI]: 0.246-0.350) versus 0.137 (95% CI: 0.105-0.174) for those without or with RBC TI, with adjusted hazard ratio (aHR) of 2.02 (95% CI: 1.44-2.84, p < 0.001). For those without and with PLT TI, the NRM incidences were 0.374 (95% CI: 0.276-0.471) and 0.179 (95% CI: 0.149-0.212), with aHR of 2.07 (95% CI: 1.30-3.29, p = 0.002). Patients with both high HCT-CI scores and lack of TI by Day 30 had the highest NRM incidence. CONCLUSION: Lack of TI by Day 30 is an early post-HCT warning sign which predicted increased 2-year NRM independently of HCT-CI and can be combined with HCT-CI to further stratify NRM risks.

Authors

Institutions

Publication Details

Journal
Vox Sanguinis
Published
2026-11-16
DOI
https://doi.org/10.1111/vox.70417
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A new red flag for non‐relapse mortality: Prolonged transfusion dependence in acute myeloid leukemia allogeneic hematopoietic cell transplant recipients

Monzr M. Al Malki, Amandeep Salhotra, Michelle Afkhami, Ryotaro Nakamura et al.
Vox Sanguinis
Hematopoietic Stem Cell Transplantation
article

A new red flag for non‐relapse mortality: Prolonged transfusion dependence in acute myeloid leukemia allogeneic hematopoietic cell transplant recipients

Monzr M. Al Malki, Amandeep Salhotra, Michelle Afkhami, Ryotaro Nakamura, Dongyun Yang, Shan Yuan, Shirong Wang
article en

Abstract

BACKGROUND AND OBJECTIVES: The hematopoietic cell transplantation comorbidity index (HCT-CI) is widely used to evaluate non-relapse mortality (NRM) risks after HCT. We aimed to evaluate whether the lack of transfusion independence (TI) by Day 30 predicted increased NRM independently of HCT-CI in acute myeloid leukemia (AML) allogeneic (allo-) HCT recipients. MATERIALS AND METHODS: The relationships between HCT-CI, TI, and NRM were evaluated using multivariate analyses in this single-center retrospective study. RESULTS: A total of 676 AML allo-HCT recipients were evaluated, including 234 (35%) with HCT-CI score ≥3. Median follow-up among survivors (n = 307) was 7.1 years (range: 2.7-11.8). High (≥3) HCT-CI score was significantly associated with increased NRM at 2 years but showed no correlation with attainment of red blood cell (RBC) or platelet (PLT) TI by Day 30. However, the lack of RBC or PLT TI by Day 30 predicted higher NRM independently of HCT-CI. The 2-year NRM incidences were 0.297 (95% confidence interval [CI]: 0.246-0.350) versus 0.137 (95% CI: 0.105-0.174) for those without or with RBC TI, with adjusted hazard ratio (aHR) of 2.02 (95% CI: 1.44-2.84, p < 0.001). For those without and with PLT TI, the NRM incidences were 0.374 (95% CI: 0.276-0.471) and 0.179 (95% CI: 0.149-0.212), with aHR of 2.07 (95% CI: 1.30-3.29, p = 0.002). Patients with both high HCT-CI scores and lack of TI by Day 30 had the highest NRM incidence. CONCLUSION: Lack of TI by Day 30 is an early post-HCT warning sign which predicted increased 2-year NRM independently of HCT-CI and can be combined with HCT-CI to further stratify NRM risks.

Vox Sanguinis
City Of Hope National Medical Center (US)
Good health and well-being
Hematopoietic Stem Cell Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon